Cas No.: 199807-33-5
PRODUCT INFORMATION
Description
Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA, also known as Cyclo(RGDfV), is a potent and selective inhibitor of integrin αvβ3. It has demonstrated cytotoxic properties in certain in vitro systems and is often used as a standard research tool in the study of integrin-mediated processes, particularly in acute myeloid leukemia (AML) cell models where this integrin is overexpressed.
Molecular Weight
688.65
Purity
> 95%
Formula
C₂₈H₃₉F₃N₈O₉
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Val]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- PSMA Targeting Peptide (CAT#: OLY-1025-YS-8)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- NGR Peptide TFA (CAT#: OLY-1025-YS-59)
- CK3 Targeting Peptide (CAT#: OLY-1025-YS-22)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.